BIO Sends Letter to President Biden Discussing Collaboration to Ensure Patient Access to COVID Treatments
March 8, 2021
BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics.
In this Post-hearing Supplementary Written Submission, BIO submits detailed comments to support the USITC investigation into the proposed WTO IP Waiver for COVID-19 therapeutics.
In this Post-hearing Supplementary Written Submission, BIO submits a 500-word summary of our position on the USITC investigation into the proposed WTO IP Waiver for COVID-19 therapeutics.
BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics.